Will Obama tax reforms quash outsourcing?

Indian pharma companies worry that President Obama's tax plans could force U.S. drugmakers to cut back on outsourcing, which would cut into their contract manufacturing and API business substantially, the Times of India writes. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.